Alimta Approval History
FDA Approved: Yes (First approved February 4, 2004)
Brand name: Alimta
Generic name: pemetrexed
Dosage form: Injection
Company: Eli Lilly
Treatment for: Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer
Alimta (pemetrexed) is an antifolate antineoplastic agent indicated for the treatment of malignant pleural mesothelioma and locally-advanced and metastatic non-small cell lung cancer (NSCLC).
Development History and FDA Approval Process for Alimta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.